共 143 条
[1]
Olivieri I(2016)Psoriatic arthritis in 2015: advancement continues in imaging, tight control and new drugs Nat Rev Rheumatol 12 76-78
[2]
D’Angelo S(2006)Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2665-2673
[3]
Taylor W(2016)Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015 Arthritis Rheumatol 68 1060-1071
[4]
Gladman D(2017)Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology Clin Exp Rheumatol 35 991-1010
[5]
Helliwell P(2016)Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey Rheumatol Ther 3 91-102
[6]
Marchesoni A(2011)Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis Arthritis Care Res (Hoboken) 63 1729-1735
[7]
Mease P(2017)Psoriatic arthritis N Engl J Med 376 957-970
[8]
Mielants H(1973)Psoriatic arthritis Semin Arthritis Rheum 3 55-78
[9]
Coates LC(2018)Current concepts and unmet needs in psoriatic arthritis Clin Rheumatol 37 297-305
[10]
Kavanaugh A(2015)What makes psoriatic and rheumatoid arthritis so different? RMD Open 1 e000025-40